As of 2024-12-15, the Relative Valuation of EGF Theramed Health Corp (TMED.CN) is (0.09) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.33 CAD, the upside of EGF Theramed Health Corp based on Relative Valuation is -126.3%.
The range of the Relative Valuation is (0.07) - (0.10) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 4.5x | 3.8x |
| Forward P/E multiples | 3.0x - 4.5x | 3.8x |
| Fair Price | (0.07) - (0.10) | (0.09) |
| Upside | -121.1% - -131.6% | -126.3% |
| Date | P/E |
| 2024-11-29 | -12.94 |
| 2024-11-26 | -10.79 |
| 2024-11-25 | -12.51 |
| 2024-11-22 | -6.69 |
| 2024-11-21 | -9.49 |
| 2024-11-20 | -10.79 |
| 2024-11-19 | -9.49 |
| 2024-11-18 | -8.63 |
| 2024-11-15 | -5.82 |
| 2024-11-14 | -1.73 |
| 2024-11-05 | -2.37 |
| 2024-11-01 | -3.02 |
| 2024-10-31 | -3.02 |